ArticleNature nanotechnology2026

A biohybrid chiral hydrogel enhances preclinical postoperative glioblastoma therapy by multi-pronged inhibition of tumour stemness.

Tingting Cui et al.PubMed ↗Publisher ↗

No numbers read from the abstract.